Anti RO (SSA) antibodies are seen in:
The core concept here is the association of anti-SSA/SSB antibodies with specific autoimmune conditions. The question is testing the knowledge of these associations. The correct answer should include Sjögren's, SLE, and neonatal lupus. Now, the options are A to D, but the user didn't provide them. However, common distractors might include other autoimmune diseases like rheumatoid arthritis or scleroderma, which don't typically have these antibodies. I need to explain why those are incorrect.
For the explanation, I'll start by stating the core concept, then explain why the correct answer is right by mentioning the diseases and their mechanisms. Then, each wrong option should be addressed. For example, if an option is rheumatoid arthritis, I can say it's incorrect because it's associated with anti-CCP or RF. The clinical pearl should highlight the importance of these antibodies in neonatal lupus, which is a high-yield fact for exams. Finally, make sure to mention the correct answer in the required format.
**Core Concept**
Anti-RO/SSA antibodies are autoantibodies targeting ribonucleoproteins involved in RNA processing. They are strongly associated with **Sjögren's syndrome**, **lupus erythematosus**, and **neonatal lupus**. These antibodies are distinct from anti-CCP or ANA, which are markers of other autoimmune conditions.
**Why the Correct Answer is Right**
Anti-RO/SSA antibodies are hallmark markers of **Sjögren's syndrome** (80–90% prevalence) and **systemic lupus erythematosus** (SLE; 20–30% prevalence). They are also linked to **neonatal lupus**, where maternal antibodies cross the placenta, causing congenital heart block or rash in the fetus. The antibodies bind to SSA/Ro autoantigens, part of the La/SSB complex, disrupting RNA metabolism and triggering immune-mediated tissue damage.
**Why Each Wrong Option is Incorrect**
**Option A:** *Rheumatoid arthritis* is characterized by **anti-cyclic citrullinated peptide (anti-CCP)** or **rheumatoid factor**, not anti-SSA.
**Option B:** *Scleroderma* is associated with **anti-Scl-70 (topoisomerase I)** or **anti-centromere** antibodies.
**Option C:** *Hashimoto’s thyroiditis* is linked to **anti-TPO** and **anti-Tg** antibodies, not anti-SSA.
**Option D:** *Psoriatic arthritis* lacks a specific antibody marker; it’s diagnosed clinically.
**Clinical Pearl / High-Yield Fact**